Top View
- Novel Antifungal Activity of Geraniol and Its Synergistic Effect in Combination with Fluconazole Against Resistant Candida Albicans
- New (& Nearly New) Antifungal Drugs for Coccidioidomycosis
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- Synergistic Activity of Micafungin Plus Voriconazole Against Multidrug-Resistant Candida Auris
- Guidelines for Treatment of Candidemia in Adults
- Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Novel Small Molecule Antifungals for Invasive Fungal Infections
- Estonian Statistics on Medicines 2017 1/42
- Antifungal Drug Repurposing
- Mycamine (Micafungin) Policy Number: C9347-A
- Antifungals of the Azole Type
- Evaluation of Carcinogenicity Studies of Medicinal Products for Human Use Authorised Via the European Centralised Procedure
- Department of Health & Human Services
- MYCAMINE® (Micafungin for Injection), for Intravenous Use ------CONTRAINDICATIONS ------Initial U.S
- Essential Medicines, Medical Countermeasures, and Critical Inputs for the List Described in Section 3(C) of the Executive Order 13944
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- Pythiosis: a Therapeutic Approach
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Potential Drug-Drug Interactions of Antiretrovirals and Antimicrobials
- Micafungin: a Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients
- A Review on Antifungal Efficiency of Plant Extracts Entrenched
- Mutual of Omaha Rx (PDP) 2021 Formulary (List of Covered Drugs)
- 21506 Micafungin Clinical BPCA
- Mycamine (Micafungin Sodium)
- Are Echinocandins Equal?
- Aspergillosis and Mucormycosis in Adults
- Onychomycosis/Fungal Apr10
- Miltefosine Against Scedosporium and Lomentospora Species: Antifungal Activity and Its Effects on Fungal Cells
- Severe Hyponatraemia Secondary to Micafungin Therapy Wilson SW Cheng 1, 2, Wei J
- Candidiasis.Pdf
- AHFS Pharmacologic-Therapeutic Classification System
- 2012 Aug (120): Treatment Guidelines
- NDA Multi-Disciplinary Review and Evaluation NDA 21506/S-023 Mycamine (Micafungin Sodium)
- Drug Class Review: Echinocandins P&T Action the Antimicrobial
- Differential in Vitro Activity of Anidulafungin, Caspofungin and Micafungin Against Candida Parapsilosis Isolates Recovered from a Burn Unit
- Antifungal Agents Spectrum of Activity, Pharmacology, and Clinical Indications
- Mycamine, INN-Micafungin
- Micafungin and Caspofungin Pharmacodynamics in Patients with Candidemia
- AAML1031 Version Date
- International ERS/ATS Consensus Definition, Mechanisms, Evaluation, and Treatment of Severe Asthma • 2013 ONLINE-ONLY SUPPLEMENT (Part 2 of 3)
- NORM Normgvet
- Increased Dose of Echinocandins for Invasive Fungal Infections: Bonanza for the Patient Or the Pharmaceutical Industry?
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- Fungal Skin Infections
- Relative Frequency of Paradoxical Growth and Trailing Effect